New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
09:04 EDTBAXBaxter names Hombach CFO
Baxter International announced that upon completion of the tax-free distribution of the company’s biopharmaceuticals business, Robert Hombach, currently CFO for Baxter International Inc., will be appointed CFO and will assume additional operational responsibilities for the independent biopharmaceuticals company. Hombach will report to Ludwig Hantson, who will serve as the new company’s CEO. James Saccaro will rejoin Baxter August 4, and will assume the role of CFO of Baxter International Inc. following completion of the transaction in 2015.
News For BAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 27, 2015
07:29 EDTBAXMarcus Evans to hold a conference
4th Annual Medical Device Safety Monitoring & Reporting Conference is being held in Las Vegas on November 27-28.
November 16, 2015
06:11 EDTBAXBaxter resumed with a Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Brooks West downgraded Baxter (BAX) to Neutral after resuming coverage of the name. The company, post the spin of Baxalta (BXLT), "has a number of moving pieces that need to be addressed," West tells investors in a research note. He lowered his price target for shares to $39 from $90.
November 13, 2015
17:04 EDTBAXThird Point gives quarterly update on stakes
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use